Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027651 (tumor)
 685,946 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Antigens expressed on urinary bladder cancer cells of transplantation and tissue culture lines, which originated in tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in individual ACI/N rats, were studied by several immunological methods. Tumor-specific transplantation antigen was determined by transplantability of cancer cells into syngeneic rats which had been immunized with the respective cancer cells by the ligation-and-release method. Two out of 6 bladder cancer lines showed high antigenicity but antigenicities of the other 4 lines were of low or undetectable level. Cross resistance was observed in the transplantation immunity among the 2 high antigenic lines but not in the other lines. Cell-mediated cytotoxicity was assayed by the microtestplate method. The lymphoid cells from ACI rats hyper-immunized with cancer cells of a high antigenic line showed a marked cytotoxicity against cancer cells of the immunizing line but not to cells of the other bladder cancer lines including another high antigenic line that induced a cross resistance in transplantation immunity. Tumor-associated cell-surface antigen was detected by membrane immunofluorescence test with serum which was raised in allogeneic Donryu rat by the high antigenic bladder cancer and absorbed with normal ACI rat tissues. The absorbed serum gave positive membrane fluorescence to cancer cells of the immunizing line and 2 other bladder cancer lines but not to cells of other 4 bladder lines and ACI tumors other than bladder cancer. The common antigen detected by the serological method was not reflected either in transplantation immunity or cell-mediated cytotoxicity of the immune lymphoid cells.
 ...
PMID:Antigen characteristics of nitrosamine-induced urinary bladder cancer in rats. 38 Oct 90

In the course of screening 35,000 urological outpatients with urine cytological examinations, cytological indication of cancer was found in 106 patients in the absence of a cystoscopically visible bladder tumor. Sixty-nine of the 106 patients have biopsy-proven in situ carcinoma of the bladder, all transitional in type and anaplastic. Follow-up data on effects of therapy are available on 58 patients treated by various means, including total cystectomy, partial cystectomy, transurethral fulguration, intravesical thiotepa, and external radiation. The duration of symptoms before diagnosis was remarkably long, and the prolonged course of the in situ lesion was also noteworthy. Differences in the observed behavior of in situ bladder carcinoma may be due, in addition to differences in host resistance, to the existence of two pathogenetic forms of bladder cancer, one arising in an extensive field of abnormal epithelium and the other developing in a focal area of abnormality.
 ...
PMID:Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. 40 39

The existence of at least two stages in bladder carcinogenesis was evaluated in male Fischer rats using N-[14-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) fed for six weeks at a level of 0.2% of the diet as the initiator. Sodium saccharin and DL-tryptophan were fed at levels of 5 and 2% of the diet, respectively, as possible promoting chemicals, and they were fed either immediately after FANFT administration or after six weeks of FANFT plus six weeks of control diet. All surviving rats were killed at the end of two years. Both chemicals significantly increased the incidence of bladder tumors following FANFT feeding compared to six weeks of FANFT feeding followed by control diet, and the results were similar whether saccharin or tryptophan feeding was started immediately after FANFT feeding was concluded or after a six-week delay. Saccharin was considerably more potent as a promoting agent than was tryptophan, inducing higher incidences of bladder tumors and having a shorter latent period. Long-term administration of FANFT induced a 100% incidence of bladder cancer. Sequential epithelial changes were observed by scanning and transmission electron microscopy as well as by light microscopy. Pleomorphic microvilli were present on the superficial cells of all tumors examined and on the surface cells of hyperplastic bladder epithelium after six weeks of FANFT plus six weeks of saccharin, but not after six weeks of FANFT and six weeks of control diet. Rats fed only saccharin tryptophan, or control diet did not have bladder tumors or pleomorphic microvilli on bladder epithelium. These data suggest that saccharin and tryptophan might act as tumor-promoting agents during bladder carcinogenesis.
 ...
PMID:Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. 42 Dec 4

In vitro sensitivity of an established cell line from human urinary bladder cancer to various chemotherapeutic agents was determined by 14C-leucine incorporation into the target cells. Of 12 drugs tested, Carboquone, Neocarzinostatin, Actinomycin D, Adriamycin, Mitomycin C and Chromomycin A3 produced intensive cytotoxic effects, while Thio-Tepa, Bleomycin, 5-Fluorouracil and Vincirstine were less cytotoxic, Intravesical instillation of Carboquone, one of the most toxic agents in vitro, resulted in complete or partial tumor remission in 6 of 9 patients with bladder cancer. Prophylactic effects of periodic intravesical Carboquone were also indicated in 7 of 8 patients who had experienced recurring superficial bladder tumors.
 ...
PMID:Chemosensitivity of human bladder cancer cells in long-term culture and clinical responses to the selected anticancer drug. 45 64

When 21 patients with bladder cancer (transitional cell carcinoma) were given local and systemic injections of a streptococcal preparation, OK-432, tumor regression was observed in 3 cases (14.3%). The marked infiltration of lymphocytes observed on histological examination of regressed tumors suggested that a host-mediated action was involved in the antitumor effect of OK-432.
 ...
PMID:Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma. 48 Apr 87

One hundred and forty-seven fully and partially evaluable patients with advanced measurable malignancies of the genitourinary and gynecologic organs were given cis-dichlorodiammineplatinum(II) at a dose of 75 mg/m2 iv every 3 weeks. Thirty-six patients with testicular neoplasms were studied; five complete responses (13.9%) and seven partial responses (PR) (19.4%) were noted. Thirty-seven patients with ovarian adenocarcinoma were evaluated; five PRs (13.5%) were seen. One complete response (11.1%) and two PRs (22.2%) were obtained among nine patients with urinary bladder cancer. Four PRs (19.0%) were seen among a group of 21 patients with advanced prostate cancer. One PR (4.8%) was noted among 21 patients with renal cell cancer and no responses were seen in eight patients with cervical cancer. There was a highly statistically significant (P less than 0.001) survival advantage for the responding testicular tumor patients. Toxicity was similar to that previously reported, with gastrointestinal side effects and nephrotoxicity most commonly seen. Prospective and sequential analysis of renal function provided strong evidence for cumulative nephrotoxicity in these patients given bolus injections of cis-dichlorodiammineplatinum(II) without prehydration or treatment with fuosemide or mannitol.
 ...
PMID:Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study. 49 55

Thirty one patients with bladder carcinoma of different grades and stages were treated by endoscopic surgery and oral administration of bacillus Calmette-Guerin (BCG). They were randomly separated in two groups: one was treated surgically and the other was treated surgically and with the BCG. According to the ability to develop an immune response to the antigens, patients were divided into three groups. The group who had been treated by endoscopic surgery only had 7 patients with recurrent bladder cancer during a median interval of 30 months. The group treated surgically and with BCG had only one patient with bladder cancer recurrence within a median follow-up period of 30 months. The results obtained with the use of BCG inducing tumor regression seem to indicate a favorable response.
 ...
PMID:[The BCG as coadjuvant in the treatment of bladder carcinoma]. 50 44

In this study, the value of urinary fibrinogen degradation products as a biological marker of bladder carcinoma has been studied. An increase in fibrinogen degradation products was found in 86% of bladder cancer patients independent of the fact that they had active tumors or that they were disease free. A highly significant correlation between the amount of the increase, the grade, local invasiveness, and the risk of recurrence of the tumor has been established. One can conclude that urinary fibrinogen degradation products are of great prognostic value in patients with bladder carcinoma.
 ...
PMID:Prognostic value of urinary fibrinogen degradation products in bladder carcinoma. 51 Mar 27

The leukocyte migration inhibition assay has demonstrated successfully tumor-associated antigenic activity in protein extracts of cell culture lines of a number of neoplasms. Our data have shown a high degree of leukocyte migration inhibition reactivity with protein extracts from the well characterized T-24 transitional carcinoma cell line. Thus, the leukocyte migration inhibition assay may prove a valuable method of in vitro assessment of the cell-mediated immunity of bladder cancer patients and as a method to monitor attempts at further purification of tumor-associated antigens.
 ...
PMID:Leukocyte migration inhibition assay in patients with bladder cancer. 51 16

The results of mapping of the urinary bladder are reported and discussed. It has been shown that Brunn's nests, cystitis cystica, and the vaginal type of squamous metaplasia are commonly found in normal bladders and thus cannot be considered as precancerous lesions. Mapping of cancerous bladders and related histologic and clinical observations strongly suggests that there are two distinct pathways in bladder neoplasia: the papillary pathway and the nonpapillary pathway. Papillary tumors with thin stalks must be considered as a focal expression of the proliferative potential of the urothelium. They are per se quite harmless but may be followed by other manifestations of neoplasia. Broad based papillary tumors, regardless of grade, may have "pushy borders," which extend into the lamina propria but rarely invade the muscularis. Nonpapillary flat lesions, notably atypical hyperplasia and carcinoma in situ, appear to be the principal source of invasive and metastasizing bladder cancer. The presence of the flat lesions puts the patient at high risk for the development of invasive carcinoma. Methods of assessment of the cancerous bladder are suggested and discussed.
 ...
PMID:Mapping of the urinary bladder: its impact on the concepts of bladder cancer. 52 59


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>